<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Clin Res Pediatr Endocrinol</journal-id>
      <journal-id journal-id-type="publisher-id">JCRPE</journal-id>
      <journal-title-group>
        <journal-title>Journal of Clinical Research in Pediatric Endocrinology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1308-5727</issn>
      <issn pub-type="epub">1308-5735</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22155465</article-id>
      <article-id pub-id-type="pmc">3245496</article-id>
      <article-id pub-id-type="doi">10.4274/jcrpe.378</article-id>
      <article-id pub-id-type="pii">129</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Resolution of Autoimmune Oophoritis after Thymectomy in a Myasthenia Gravis Patient</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>&#xC7;ak&#x131;r</surname>
            <given-names>Esra Deniz Papatya</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xD6;zdemir</surname>
            <given-names>&#xD6;zlem</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eren</surname>
            <given-names>Erdal</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sa&#x11F;lam</surname>
            <given-names>Halil</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okan</surname>
            <given-names>Mehmet</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tar&#x131;m</surname>
            <given-names>&#xD6;mer Faruk</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
				Uluda&#x11F; University School of Medicine, Pediatric Endocrinology, Bursa, Turkey
			</aff>
      <aff id="A2"><label>2</label>
				Uluda&#x11F; University School of Medicine, Pediatric Neurology, Bursa, Turkey
			</aff>
      <aff>
        <phone>+90 224 442 81 43</phone>
        <email>edpapatya@yahoo.com</email>
        <addr-line>Uluda&#x11F; University School of Medicine, Pediatric Endocrinology, Bursa, Turkey 

</addr-line>
      </aff>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>12</month>
        <year>2011</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>212</fpage>
      <lpage>215</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>8</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Myasthenia gravis (MG) is an autoimmune disorder characterized  by autoantibodies against acetylcholine receptors. MG is generally an isolated disorder but may occur concomitantly with other autoimmune diseases. We describe an eighteen-year-old girl with MG who was admitted to our clinic with secondary amenorrhea and diagnosed as autoimmune oophoritis. Since her myasthenic symptoms did not resolve with anticholinesterase therapy, thymectomy was performed. After thymectomy, her menses have been regular without any hormonal replacement therapy. To our knowledge, this is the first report on a patient with autoimmune ovarian insufficiency and MG in whom  premature ovarian insufficiency resolved after thymectomy, without  hormonal therapy.</p>
        <p><bold>Conflict of interest:</bold>None declared.</p>
      </abstract>
      <kwd-group>
        <kwd>Autoimmune oophoritis</kwd>
        <kwd>myasthenia gravis</kwd>
        <kwd>thymectomy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Myasthenia gravis (MG) is an autoimmune disorder characterized by autoantibodies against acetylcholine receptors (<xref ref-type="bibr" rid="ref1">1</xref>). MG is generally an isolated disorder but a minority of patients may develop MG in conjunction with other autoimmune organ failures such as autoimmune thyroid diseases, rheumatoid arthritis, pernicious anemia and systemic lupus erythematosus (<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>). Premature ovarian failure (POF) has been very rarely reported in association with MG. We report a case with MG in whom POF has resolved after thymectomy.</p>
    </sec>
    <sec>
      <title>CASE REPORTS</title>
      <p>An eighteen-year-old girl with a six-month-history of secondary amenorrhea was admitted to our pediatric endocrinology clinic. Her past medical history was remarkable for MG, presenting with ptosis and generalized muscle weakness developing at the end of the day. She was fifteen years old when she was diagnosed as having autoimmune MG. Her symptoms were partially resolved with pyridostigmine bromide (120 mg/day) and at the eleventh month of this therapy, prednisolone (60 mg/day) was added. After two months of prednisolone treatment, psychiatric symptoms appeared which were attributed to drug-induced bipolar affective disorder and steroid treatment was gradually discontinued. The antipsychotic olanzapine (15 mg/day) was started. Her menstrual cycles had started when she was twelve years old and were regular until thirteen months after the diagnosis of MG and at the third month of olanzapine therapy, when menstrual irregularity had appeared. Her family history was unremarkable. There was no pathologic finding in her physical examination. Her pubertal development was evaluated as Tanner stage 5.</p>
      <p>Since neuroleptic drugs can increase serum prolactin levels and cause menstrual irregularity, the patient&#x2019;s prolactin level was checked and found normal. Her gonadotropin and inhibin B levels were in postmenapausal ranges (follicle stimulating hormone: 56.23 mIU/mL, luteinizing hormone  25.43 mIU/mL, inhibin B&lt;10 pg/mL) and estrogen level was 18 pg/mL. The patient&#x2019;s hormonal levels are shown chronologically from the beginning of the menstrual irregularity in <xref ref-type="table" rid="T2">Table 1</xref>. Primary ovarian insufficiency was evident with these hormonal levels. Her suprapubic pelvic ultrasonography revealed a large cystic formation (57x95x112 mm) in her left ovary. For etiological investigation of autoimmune POF (APOF), we checked antiovarian antibodies and the antibodies against the 21-hydroxylase enzyme. They were all negative. Acetylcholine receptor antibodies were found to be positive at the beginning of the myasthenic symptoms. Antithyroid peroxidase and antityroglobulin antibodies were also negative. We could not measure steroidogenic cell antibodies. The patient&#x2019;s myasthenic symptoms did not resolve with anticholinesterase therapy, and thymic enlargement was detected by thorax magnetic resonance imaging. Since there is a general consensus that patients with generalised MG between puberty and 60 years of age may benefit from thymectomy, this surgical procedure  was performed and pathologic examination revealed follicular thymic hyperplasia. Three months after thymectomy, her regular menses started. Gonadotropin levels decreased to normal ranges, but her left ovarian cyst persisted. Six months after thymectomy, her left ovarian cyst was removed. Pathological diagnosis was benign mucinous cyst. Her menstrual bleeding has been regular since thymectomy, without any hormonal replacement therapy.</p>
      <table-wrap id="T2" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <title>Laboratory evaluation of the patient in a chronological order</title>
        </caption>
        <graphic xlink:href="JCRPE-3-212-g1"/>
      </table-wrap>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>POF is characterized by amenorrhea, hypoestrogenism and elevated serum gonadotropin levels in women younger than 40 years (<xref ref-type="bibr" rid="ref6">6</xref>). Among a total of 266 POF patients, 4% of  patients with spontaneous POF were diagnosed to have autoimmune oophoritis (AO) (<xref ref-type="bibr" rid="ref7">7</xref>). An autoimmune mechanism was described in some patients with lymphocytic and plasma cell infiltration in developing follicles (<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref>). The only validated marker to detect AO is the presence of steroidogenic cell autoantibodies (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref11">11</xref>). </p>
      <p>Coexistence of autoimmune ovarian failure and other autoimmune diseases was reported to be between 10% and 55% (<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref>).  APOF could be seen as a part of autoimmune 1polyglandular syndrome type 1 (APGST1) (72%) and APGST2 (10%) at the age of 40 years (<xref ref-type="bibr" rid="ref14">14</xref>). It was also reported that 12-33% of women who presented with APOF had autoimmune thyroid disease as well (<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref>). APOF was also observed in patients with systemic lupus erythematosus  and MG (<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref>). APOF and adrenal autoimmunity coexistence is the  best known but not the most frequent association. Histological confirmation of  APOF was first reported in a patient with autoimmune adrenal insufficiency (<xref ref-type="bibr" rid="ref8">8</xref>). There was lymphocytic infiltration in the secondary and antral follicles, but primordial follicles were spared (<xref ref-type="bibr" rid="ref21">21</xref>). Lymphocytic infiltration was most intense in the theca layer of the developing follicles and related with the intense luteinization of the follicles (<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref>). Ovarian biopsy is not recommended for the confirmation of the diagnosis in APOF. In one study (<xref ref-type="bibr" rid="ref22">22</xref>), highly elevated total inhibin and inhibin B serum levels were reported in patients with APOF compared to patients with idiopathic POF and natural menopause. Increased inhibin B level was thought to be  a result of the initial preservation of granulosa cell functions. As the disease advances, ovaries can become atrophic. In our patient, inhibin B level was in postmenauposal range and estrogen levels were low. We thought that this postmenopausal inhibin B level was the result of an advanced stage of the ovarian destruction in our patient. We did not perform ovarian biopsy at the time of diagnosis. However, six months after thymectomy, a benign mucinous ovarian cyst was removed. The pathology of the cyst showed no lymphocytic and plasma cell infiltration. At the time of the ovarian operation, our patient had been having regular menstrual bleeding and normal gonadotropin and sex steroid levels for six months. We thought that this was the reason we could not find lymphocytic and plasma cell infiltration representing AO.  However, it has been recently reported that lymphocytic and plasma cell infiltration may be absent and selective mononuclear cell infiltration free of lymphocytes may be observed in AO (<xref ref-type="bibr" rid="ref23">23</xref>). Antibodies against steroid cell antigens obtained from adrenal tissue substrates are the most validated marker for the diagnosis of APOF that correlates with ovarian inflammation (<xref ref-type="bibr" rid="ref7">7</xref>). We could only study anti-21-hydroxylase and antiovarian antibodies and they were negative. The predictive value of the commercially available antiovarian antibody test is poor. One study (<xref ref-type="bibr" rid="ref24">24</xref>) showed that these tests use animal ovarian tissues and have an unacceptably high false-positive rate.</p>
      <p>Large ovarian cysts have been reported in several patients with AOF. As a result of follicular dysfunction, impaired negative feedback lead to elevated gonadotropin levels which overstimulate the ovarian tissues and lead to the development of large luteinized ovarian cysts (<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref>,<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref>). Initially, we thought that our patient&#x2019;s large ovarian cyst had developed with this mechanism. However, we did not observe any regression in this large ovarian cyst after thymectomy although her regular menstruation resumed.  On the other hand, thymectomy has been reported to induce autoimmune ovarian dysgenesis and autoimmune dacryoadenitis in mice. However, the significance of this finding in humans especially in the setting of MG is not clear (<xref ref-type="bibr" rid="ref30">30</xref>).</p>
      <p>Coexistence with another autoimmune disease is not a criterion for the diagnosis of APOF. However, our patient had primary ovarian failure and her ovarian insufficiency resolved after thymectomy. For this reason, we thought she had AO. </p>
      <p>There is no controlled research about the treatment of AOF, but steroid therapy 20-40 mg/day and cyclic estrogen-progesterone replacement therapy have been reported to be successful in several case reports and case series in adults (<xref ref-type="bibr" rid="ref31">31</xref>). We did not use steroid therapy, because our patient had developed steroid-related bipolar affective disorder during the therapy for MG. In 1969, Lundberg and Person   reported a 25-year-old MG female patient with POF and her menstrual cycles became regular eight weeks after thymectomy (<xref ref-type="bibr" rid="ref5">5</xref>). The authors thought that her ovarian failure had an autoimmune etiology.  In 1993, a 27-year-old patient with POF and MG was reported to have had thymectomy one year after the initial diagnosis during which she received   pyridostigmine and hormone replacement therapy. Spontaneous pregnancy occurred three years after thymectomy (<xref ref-type="bibr" rid="ref32">32</xref>). </p>
      <p>Our patient was not on hormonal replacement before and after thymectomy. Her regular menses started three months after thymectomy. To our knowledge, this is the first report on a patient with autoimmune ovarian insufficiency and MG in whom premature ovarian insufficiency resolved after thymectomy without hormonal therapy. We therefore suggest that treatment of MG including thymectomy if indicated may lead to resolution of the ovarian failure and hormonal therapy may not be necessary. If hormonal therapy had been </p>
      <p>introduced before MG was successfully treated; a trial of discontuniation of cyclic hormone replacement may reveal ovarian recovery.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="book" publication-format="print">
          <person-group person-group-type="author">
            <name>
              <surname>Sarnat</surname>
              <given-names>B.H</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Behrman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kliegman</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Jenson</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <chapter-title>Disorders of neuromuscular transmission and of motor neurons</chapter-title>
          <source>Nelson Textbook of Pediatrics</source>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Saunders</publisher-name>
          <year>2004</year>
          <fpage>191</fpage>
          <lpage>242</lpage>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Myasthenia gravis and premature ovarian failure</article-title>
          <source>Muscle Nerve</source>
          <year>2004</year>
          <volume>30</volume>
          <fpage>231</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">15266640</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Bateman</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Nunley WC</surname>
              <given-names>Jr</given-names>
            </name>
            <name>
              <surname>Kitchin JD</surname>
              <given-names>3rd</given-names>
            </name>
          </person-group>
          <article-title>Reversal of apparent premature ovarian failure in a patient with myasthenia gravis</article-title>
          <source>Fertil Steril</source>
          <year>1983</year>
          <volume>39</volume>
          <fpage>108</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">6293884</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Kuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Tucci</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Myasthenia gravis and premature ovarian failure</article-title>
          <source>Arch Intern Med</source>
          <year>1981</year>
          <volume>141</volume>
          <fpage>1230</fpage>
          <lpage>1232</lpage>
          <pub-id pub-id-type="pmid">6266360</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Lundberg</surname>
              <given-names>PO</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>BH</given-names>
            </name>
          </person-group>
          <article-title>Disappearance of amenorrhea after thymectomy. A case report</article-title>
          <source>Acta Soc Med Ups</source>
          <year>1969</year>
          <volume>74</volume>
          <fpage>206</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="pmid">5212570</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Forges</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Monnier- Barbarino</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Faure</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Bene</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Autoimmunity and antigenic targets in ovarian pathology</article-title>
          <source>Hum Reprod Update</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>163</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="pmid">15073145</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Bakalov</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Anasti</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Calis</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Vanderhoof</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Premkumar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Furmaniak</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Merino</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure</article-title>
          <source>Fertil Steril</source>
          <year>2005</year>
          <volume>84</volume>
          <fpage>958</fpage>
          <lpage>965</lpage>
          <pub-id pub-id-type="pmid">16213850</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Irvine</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Scarth</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kolb</surname>
              <given-names>FO</given-names>
            </name>
            <name>
              <surname>Hartog</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bayliss</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Drury</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Immunological aspects of premature ovarian failure associated with idiopathic Addison&#x2019;s disease</article-title>
          <source>Lancet</source>
          <year>1968</year>
          <volume>2</volume>
          <fpage>883</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="pmid">4176147</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Bannatyne</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Russel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shearman</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune oophoritis: a clinicopathologic assesment of 12 cases.</article-title>
          <source>Int Gynecol Pathol</source>
          <year>1990</year>
          <volume>9</volume>
          <fpage>191</fpage>
          <lpage>207</lpage>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Gloor</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hurlimann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune oophoritis</article-title>
          <source>Am J Clin Pathol</source>
          <year>1984</year>
          <volume>81</volume>
          <fpage>105</fpage>
          <lpage>109</lpage>
          <pub-id pub-id-type="pmid">6691297</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Welt</surname>
              <given-names>CK</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune oophoritis in the adolescent</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2008</year>
          <volume>1135</volume>
          <fpage>118</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="pmid">18574216</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Coulam</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>The prevalance of autoimmune disorders among patients with primary ovarian failure</article-title>
          <source>Am J Reprod Immunol</source>
          <year>1983</year>
          <volume>4</volume>
          <fpage>63</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">6650708</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>de Moraes-Reuhsen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Blizzard</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Garcia-Bunuel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Autoimmunity and ovarian failure</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>1972</year>
          <volume>112</volume>
          <fpage>693</fpage>
          <lpage>703</lpage>
          <pub-id pub-id-type="pmid">4551032</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Perheentupa</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>APS-1/APECED: the clinical disease and therapy</article-title>
          <source>Endocrinol Metab Clin North  Am</source>
          <year>2002</year>
          <volume>31</volume>
          <fpage>295</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">12092452</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Rebar</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Erickson</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Yen</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>&#x130;diopathic premature ovarian failure: clinical and endocrine characteristics</article-title>
          <source>Fertil Steril</source>
          <year>1982</year>
          <volume>37</volume>
          <fpage>35</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">6800842</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Alper</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Garner</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Premature ovarian failure: its relationship to autoimmune disease.</article-title>
          <source>Obstet Gynecol</source>
          <year>1985</year>
          <volume>66</volume>
          <fpage>27</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">4011067</pub-id>
        </element-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Betterle</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dalla Pria</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Artifoni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pedini</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gavasso</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Caretto</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Premature ovarian failure : autoimmunity and natural history</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>1993</year>
          <volume>39</volume>
          <fpage>35</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">8348706</pub-id>
        </element-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Pekonen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Seigberg</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Makinen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miettinen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yli-Korkala</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Immunological disturbances in patients with premature ovarian failure</article-title>
          <source>Clin Endocrinol (Oxf)</source>
          <year>1986</year>
          <volume>25</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">3539415</pub-id>
        </element-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>LaBarbera</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Ober</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rebar</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune etiology in premature ovarian failure</article-title>
          <source>Am J Reprod Immunol Microbiol</source>
          <year>1988</year>
          <volume>16</volume>
          <fpage>115</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="pmid">3289410</pub-id>
        </element-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Escobar</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Cigorraga</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Chiauzzi</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Charreau</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Rivarola</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: suggestion of similar autoimmune mechanisms</article-title>
          <source>Acta Endocrinol (Copenh)</source>
          <year>1982</year>
          <volume>99</volume>
          <fpage>431</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="pmid">6280429</pub-id>
        </element-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Sedmak</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Tubbs</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate</article-title>
          <source>Int J Gynecol Pathol</source>
          <year>1987</year>
          <volume>6</volume>
          <fpage>73</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">3570633</pub-id>
        </element-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Tsigkou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marzotti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Borges</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Brozzetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Candeloro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Luisa Bacosi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bini</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Petraglia</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Falorni</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>High seum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2008</year>
          <volume>93</volume>
          <fpage>1263</fpage>
          <lpage>1269</lpage>
          <pub-id pub-id-type="pmid">18211971</pub-id>
        </element-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>La Marca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brozzetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sighinolfi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Marzotti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Volpe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Falomi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Primary ovarian insufficieny : autoimmune causes</article-title>
          <source>Curr Opin Obstet Gynecol</source>
          <year>2010</year>
          <volume>22</volume>
          <fpage>277</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">20543691</pub-id>
        </element-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Novosad</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kalantaridou</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Tong</surname>
              <given-names>ZB</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Ovarian antibodies as detected by indirect immunofluorescence are 
unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation</article-title>
          <source>BMC Womens Health</source>
          <year>20003</year>
          <volume>3</volume>
          <fpage>2</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">12694633</pub-id>
        </element-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Biscotti</surname>
              <given-names>CV</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Lucas</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Cystic ovarian enlargement resulting from autoimmune oophoritis</article-title>
          <source>Obstet Gynecol</source>
          <year>1989</year>
          <volume>74</volume>
          <fpage>492</fpage>
          <lpage>495</lpage>
          <pub-id pub-id-type="pmid">2761940</pub-id>
        </element-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Burrell</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Murdoch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Angus</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune ovarian failure with elevated serum levels of luteinizing hormone and enlarged ovaries. Case report</article-title>
          <source>Br J Obstet Gynaecol</source>
          <year>1990</year>
          <volume>97</volume>
          <fpage>362</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="pmid">2340260</pub-id>
        </element-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Lonsdale</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Trowell</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Autoimmune oophoritis associated with polycystic ovaries</article-title>
          <source>Histopathology</source>
          <year>1991</year>
          <volume>19</volume>
          <fpage>77</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">1916689</pub-id>
        </element-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Welt</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotrophic hypogonadism or premature ovarian failure</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2005</year>
          <volume>90</volume>
          <fpage>826</fpage>
          <lpage>830</lpage>
          <pub-id pub-id-type="pmid">15562017</pub-id>
        </element-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Welt</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Falorni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels.</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2005</year>
          <volume>90</volume>
          <fpage>3069</fpage>
          <lpage>3076</lpage>
          <pub-id pub-id-type="pmid">15705922</pub-id>
        </element-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>del Rio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Alard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tung</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Teuscher</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>H2 control of  natural T regulatory cell frequecy in the lymph node correlates with susceptibility today 3 thymectomy-induced autoimmune disease</article-title>
          <source>J Immunol</source>
          <year>2011</year>
          <volume>186</volume>
          <fpage>382</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="pmid">21135167</pub-id>
        </element-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Kalantaridou</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Braddock</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Patronas</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>Treatment of autoimmune premature ovarian failure</article-title>
          <source>Hum Reprod</source>
          <year>1999</year>
          <volume>14</volume>
          <fpage>1777</fpage>
          <lpage>1782</lpage>
          <pub-id pub-id-type="pmid">10402388</pub-id>
        </element-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Haines</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Yip</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Case report: spontaneous pregnancy following thymectomy for myasthenia gravis associated with premature ovarian failure</article-title>
          <source>Asia Oceania J Obstet Gynaecol</source>
          <year>1993</year>
          <volume>19</volume>
          <fpage>253</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">8250758</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
